Formoterol For Asthma: Evidence Of Serious Adverse Effects, Cochrane Researchers Review

10/17/2008 7:13:58 AM

ScienceDaily (Oct. 17, 2008) — Asthma sufferers who regularly take the beta2-agonist formoterol are more likely to suffer non-fatal serious adverse events than those given placebos. A review carried out by Cochrane Researchers showed a significantly increased risk for people who took the drug once or twice daily for at least 12 weeks.

Read at ScienceDaily

Read at MedPageToday

Read Article at

Related Companies

News Categories

• ScienceDaily

• MedPageToday

• Academic / Research - Research news

• Clinical - Recalls and Warnings

• Academic / Research - Research news (World)

• Clinical - Recalls and Warnings (World)